Moving forward with a value-driven strategy. The 4C name was conceived from a value-first approach for our patients and doctors – which is why Care, Commitment, Choice and Change are more than just concepts to us; they are the very foundation on which our company was built.
This is reflected in the team that we have spent the last several years assembling that spans compliance, cultivation, technology, engineering and healthcare. A team with the sole focus of revolutionising medical cannabis for both patients and doctors in the UK.
4C LABS team includes Hannah Deacon, who has publicly championed access to cannabis based products for treatment of refractory epilepsies in Pediatrics. 4C LABS will work with patients and physicians to improve accessibility and availability for those who need treatment the most.
UK patients deserve access to medicines that have been tested, certified and grown organically using proven cannabis genetics. With a deep understanding of plant genetics and innovative dosing strategies, 4C LABS delivers custom tailored solutions to address patients’ specific needs.
4C LABS’ cultivation strategy is spear-headed by a Canadian Master Grower with 25+ years experience supplying sought after products to compassion centres that serve the cancer community and others who suffer from chronic illnesses
4C LABS is building a telehealth platform that offers automated consultations and streamlines the patient prescription process. In turn, our partnership with the Medical Cannabis Clinicians Society broadens our educational reach and network within the UK medical community.
Further National Health-Service Information on